High dimensional precision medicine from patient-derived xenografts
  The complexity of human cancer often results in significant heterogeneity in
response to treatment. Precision medicine offers potential to improve patient
outcomes by leveraging this heterogeneity. Individualized treatment rules
(ITRs) formalize precision medicine as maps from the patient covariate space
into the space of allowable treatments. The optimal ITR is that which maximizes
the mean of a clinical outcome in a population of interest. Patient-derived
xenograft (PDX) studies permit the evaluation of multiple treatments within a
single tumor and thus are ideally suited for estimating optimal ITRs. PDX data
are characterized by correlated outcomes, a high-dimensional feature space, and
a large number of treatments. Existing methods for estimating optimal ITRs do
not take advantage of the unique structure of PDX data or handle the associated
challenges well. In this paper, we explore machine learning methods for
estimating optimal ITRs from PDX data. We analyze data from a large PDX study
to identify biomarkers that are informative for developing personalized
treatment recommendations in multiple cancers. We estimate optimal ITRs using
regression-based approaches such as Q-learning and direct search methods such
as outcome weighted learning. Finally, we implement a superlearner approach to
combine a set of estimated ITRs and show that the resulting ITR performs better
than any of the input ITRs, mitigating uncertainty regarding user choice of any
particular ITR estimation methodology. Our results indicate that PDX data are a
valuable resource for developing individualized treatment strategies in
oncology.
